author-photo

Richann Liu

Pfizer

4

Papers

18

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Pharmacokinetic and pharmacodynamic effects of a γ‐secretase modulator, PF‐06648671, on CSF amyloid‐β peptides in randomized Phase 1 studies

2019 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (11)
SAFETY, TOLERABILITY, AND PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF PF-06751979, A POTENT AND SELECTIVE ORAL BACE1 INHIBITOR: RESULTS FROM PHASE1 SINGLE AND MULTIPLE ASCENDING DOSE STUDIES IN HEALTHY YOUNG AND OLDER VOLUNTEERS

2017 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (2)
PF-06648671–A NOVEL GAMMA SECRETASE MODULATOR: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFECTS ON PLASMA AMYLOID-B LEVELS FOLLOWING SINGLE ORAL ASCENDING DOSES IN HEALTHY VOLUNTEERS

2016 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (4)